Cyclic peptide interleukin 5 antagonists mimic CD turn recognition epitope for receptor α
暂无分享,去创建一个
I. Chaiken | Madhushree Bhattacharya | I. Uings | G. Váradi | Piotr Ruchala | D. V. Ryk | P. Ruchala | T. Ishino | Tetsuya Ishino | Madhushree Bhattacharya | Cecilia Urbina | Irwin Chaiken | Gyorgyi Varadi | Jeffery Scibek | Donald Van Ryk | Iain Uings | J. Scibek | C. Urbina
[1] N. Skelton,et al. Amino acid determinants of beta-hairpin conformation in erythropoeitin receptor agonist peptides derived from a phage display library. , 2002, Journal of molecular biology.
[2] J. Tavernier,et al. A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific α chain and a β chain shared with the receptor for GM-CSF , 1991, Cell.
[3] C. Pace,et al. How to measure and predict the molar absorption coefficient of a protein , 1995, Protein science : a publication of the Protein Society.
[4] I. Wilson,et al. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. , 1999, Science.
[5] A. Beresford,et al. Modified peptide antagonists of interleukin 5 exhibit extended in vivo persistence but restricted species specificity. , 2001, Cytokine.
[6] M. Migita,et al. Molecular cloning and expression of the human interleukin 5 receptor , 1992, The Journal of experimental medicine.
[7] V. Mordvinov,et al. Biological and molecular characteristics of interleukin-5 and its receptor. , 1998, International reviews of immunology.
[8] M. Doyle,et al. Monomeric isomers of human interleukin 5 show that 1:1 receptor recruitment is sufficient for function. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[9] M. Vadas,et al. GM-CSF, IL-3 and IL-5: cross-competition on human haemopoietic cells. , 1992, Immunology today.
[10] I. Chaiken,et al. Coiled coil miniprotein randomization on phage leads to charge pattern mimicry of the receptor recognition determinant of interleukin 5 , 2002, Journal of molecular recognition : JMR.
[11] Nicos Nicola,et al. Guidebook to cytokines and their receptors , 1994 .
[12] R. Woody. Chapter 2 – Circular Dichroism of Peptides , 1985 .
[13] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[14] M. Lambert,et al. A novel dimer configuration revealed by the crystal structure at 2.4 Å resolution of human interleukin-5 , 1993, Nature.
[15] Rabindra Tambyraja,et al. Epitope Randomization Redefines the Functional Role of Glutamic Acid 110 in Interleukin-5 Receptor Activation* , 2000, The Journal of Biological Chemistry.
[16] Emma Evergren,et al. Biosensor analysis of dynamics of interleukin 5 receptor subunit βc interaction with IL5:IL5Rα complexes , 2002 .
[17] C. Sanderson. Interleukin-5: From Molecule to Drug Target for Asthma , 1998 .
[18] G. Fasman,et al. Computed circular dichroism spectra for the evaluation of protein conformation. , 1969, Biochemistry.
[19] N. Greenfield. Methods to estimate the conformation of proteins and polypeptides from circular dichroism data. , 1996, Analytical biochemistry.
[20] J. Tavernier,et al. Recombinant soluble human interleukin-5 (hIL-5) receptor molecules. Cross-linking and stoichiometry of binding to IL-5. , 1993, The Journal of biological chemistry.
[21] E. Whitehorn,et al. A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor alpha chains. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[22] M. Peitsch,et al. Identification of Key Charged Residues of Human Interleukin-5 in Receptor Binding and Cellular Activation (*) , 1995, The Journal of Biological Chemistry.
[23] I. Chaiken,et al. Multisite mutagenesis of interleukin 5 differentiates sites for receptor recognition and receptor activation. , 2000, Biochemistry.
[24] S. Carr,et al. Binding interactions of human interleukin 5 with its receptor alpha subunit. Large scale production, structural, and functional studies of Drosophila-expressed recombinant proteins. , 1995, The Journal of biological chemistry.
[25] J. Tavernier,et al. Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[26] G. Fasman,et al. Conformational analysis of pseudocyclic hexapeptides based on quantitative circular dichroism (CD), NOE, and x-ray data. The pure CD spectra of type I and type II .beta.-turns , 1991 .
[27] G. Fasman,et al. Quantitative analysis of cyclic β‐turn models , 1992, Protein science : a publication of the Protein Society.
[28] I. Chaiken,et al. Single Chain Human Interleukin 5 and Its Asymmetric Mutagenesis for Mapping Receptor Binding Sites (*) , 1996, The Journal of Biological Chemistry.
[29] R. Cook,et al. Mutants of Single Chain Interleukin 5 Show Asymmetric Recruitment of Receptor α and βc Subunits* , 1996, The Journal of Biological Chemistry.
[30] G Canziani,et al. Randomization of the Receptor α Chain Recruitment Epitope Reveals a Functional Interleukin-5 with Charge Depletion in the CD Loop* , 1999, The Journal of Biological Chemistry.
[31] R. Cook,et al. Mutagenesis in the C-terminal region of human interleukin 5 reveals a central patch for receptor alpha chain recognition. , 1995, Proceedings of the National Academy of Sciences of the United States of America.